EUVIMED · CrossrefZeitschrift
Biomarker Research
ISSN 2050-7771 · Springer Science and Business Media LLC
Neueste Artikel
Immunometabolic and epigenetic reprogramming in inflammatory bowel disease: from mechanistic circuits to therapeutic targeting
FGFBPs in health and tumors: emerging prognostic biomarkers and therapeutic implications
Prognostic scores and biomarkers in hematologic malignancies: current evidence and future perspectives
Multi-omics, multi-tissue analysis reveal role of extracellular matrix remodeling and sphingolipid homeostasis in edematous malnutrition (kwashiorkor)
IL-6/CD147-augmented CAR macrophages enhance the antitumor activity of CAR-T cells in solid tumor models
Adult-onset familial hemophagocytic lymphohistiocytosis has distinct genetic architecture and outcomes: a nationwide multicenter cohort study in China
Immune checkpoints: cross-disease insights and clinical dilemmas
Synergistic efficacy of the EGFR inhibitor osimertinib with the XPO1 inhibitor selinexor in T-cell acute lymphoblastic leukemia
Targeted protein degradation in cancer: strategies for undruggable targets and progress towards clinical translation
CD73-targeted CAR-NK cell therapy displays potent antitumor activity and translational potential in relapsed/refractory lung adenocarcinoma
Intra-aortic balloon pump use and in-hospital mortality in acute myocardial infarction with Killip class III or IV: a nationwide cohort study
The role of biomarkers across the care continuum in acute heart failure
Advances, challenges, and innovative strategies of CAR-T cell therapy in pancreatic cancer
Targeting lysosome-dependent cell death in cancer: towards therapeutic strategies
Guided immunotherapy for residual solid tumor: integrating platelets and CAR T cells to reduce post-surgical recurrence
Decoding the microbiome-immune crosstalk in cancer: from mechanisms to therapeutic translation
In vivo CAR-T therapy: latest updates from the 2025 ASH annual meeting
Circulating biomarkers of carotid plaque vulnerability: current evidence, emerging markers, and barriers to clinical implementation
Inflammation and wound healing: a comprehensive overview of mechanisms, therapeutic strategies, and translational perspectives
Targeted protein degradation for fetal hemoglobin induction: a new paradigm in β-hemoglobinopathy therapy
tRNA modifications in cancer: from molecular mechanisms to clinical translation
Multi-omics biomarkers in female fertility: from oocyte quality to endometrial receptivity and clinical translation
Clinical application of PARP inhibitors and emerging strategies to overcome resistance: a pan-cancer perspective
T-cell-targeted fusogenic nanovesicles generate CAR-T cells in vivo for rheumatoid arthritis therapy
Semaphorins: from CD8⁺ T cells to cancer immunotherapy
Precision oncology in a dish: patient-derived glioma organoids to guide novel therapeutic strategies
Mitochondrial DNA mutations and intercellular mitochondrial transfer in cancer: mechanisms, biological effects, and clinical potential
Emerging roles of circular RNAs and enhancer RNAs: new insights into the development and management of neurodegenerative disorders
Isolation and typing techniques for circulating tumor cells
Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications
EUVIMED